Journal
CANCER LETTERS
Volume 313, Issue 1, Pages 15-25Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2011.08.020
Keywords
Intraoperative radiotherapy; Breast neoplasms; Systematic review
Categories
Funding
- European Regional Development Fund (ERDF) [PI08/90443]
- National Plan for Scientific Research, Development and Technological Innovation as an evaluation research project in Health Technologies
- Carlos III Health Institute
Ask authors/readers for more resources
The objective of this study is to assess the efficacy and safety of intraoperative radiotherapy (IORT) for early breast cancer through a systematic review. Fifteen studies met the inclusion criteria. Most studies assessed the combined treatment with IORT (10-24 Gy) and external beam radiotherapy (EBRT) (45-50 Gy) on early stage breast cancer (T0-2). Local control was over 95% for 1 and 4 years of follow-up and the 5-year overall survival was 99%. The TARGIT-A study found a similar survival comparing IORT with standard treatment. The incidence of acute and chronic complications was scarce. IORT is well tolerated by patients and acute and late toxicities are low. There are no differences in survival for IORT treated patients versus standard treatment. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available